1 Market Overview
1.1 CAR-T Cell Therapy Introduction
1.2 Market Analysis by Type
1.2.1 CD 19
1.2.2 CD 20
1.2.3 GD2
1.2.4 CD22
1.2.5 CD30
1.2.6 CD33
1.2.7 HER1
1.2.8 HER2
1.2.9 Meso
1.2.10 EGFRvlll
1.3 Market Analysis by Application
1.3.1 Acute Lymphoblastic Leukemia (ALL)
1.3.2 Chronic lymphocytic leukemia (CLL)
1.3.3 Non-Hodgkin lymphoma
1.3.4 Acute myeloid leukemia (AML)
1.3.5 Neuroblastoma
1.3.6 Multiple myeloma (MM)
1.3.7 Others
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global CAR-T Cell Therapy Market Size Analysis from 2015 to 2028
1.6.1 Global CAR-T Cell Therapy Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global CAR-T Cell Therapy Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global CAR-T Cell Therapy Price Trends Analysis from 2015 to 2028
2 Global CAR-T Cell Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global CAR-T Cell Therapy (Volume and Value) by Type
2.1.1 Global CAR-T Cell Therapy Consumption and Market Share by Type (2015-2020)
2.1.2 Global CAR-T Cell Therapy Revenue and Market Share by Type (2015-2020)
2.2 Global CAR-T Cell Therapy (Volume and Value) by Application
2.2.1 Global CAR-T Cell Therapy Consumption and Market Share by Application (2015-2020)
2.2.2 Global CAR-T Cell Therapy Revenue and Market Share by Application (2015-2020)
2.3 Global CAR-T Cell Therapy (Volume and Value) by Region
2.3.1 Global CAR-T Cell Therapy Consumption and Market Share by Region (2015-2020)
2.3.2 Global CAR-T Cell Therapy Revenue and Market Share by Region (2015-2020)
3 United States CAR-T Cell Therapy Market Analysis
3.1 United States CAR-T Cell Therapy Consumption and Value Analysis
3.2 United States CAR-T Cell Therapy Consumption Volume by Type
3.3 United States CAR-T Cell Therapy Consumption Structure by Application
4 Europe CAR-T Cell Therapy Market Analysis
4.1 Europe CAR-T Cell Therapy Consumption and Value Analysis
4.2 Europe CAR-T Cell Therapy Consumption Volume by Type
4.3 Europe CAR-T Cell Therapy Consumption Structure by Application
4.4 Europe CAR-T Cell Therapy Consumption by Top Countries
4.4.1 Germany CAR-T Cell Therapy Consumption Volume from 2015 to 2020
4.4.2 UK CAR-T Cell Therapy Consumption Volume from 2015 to 2020
4.4.3 France CAR-T Cell Therapy Consumption Volume from 2015 to 2020
4.4.4 Italy CAR-T Cell Therapy Consumption Volume from 2015 to 2020
4.4.5 Spain CAR-T Cell Therapy Consumption Volume from 2015 to 2020
4.4.6 Poland CAR-T Cell Therapy Consumption Volume from 2015 to 2020
4.4.7 Russia CAR-T Cell Therapy Consumption Volume from 2015 to 2020
5 China CAR-T Cell Therapy Market Analysis
5.1 China CAR-T Cell Therapy Consumption and Value Analysis
5.2 China CAR-T Cell Therapy Consumption Volume by Type
5.3 China CAR-T Cell Therapy Consumption Structure by Application
6 Japan CAR-T Cell Therapy Market Analysis
6.1 Japan CAR-T Cell Therapy Consumption and Value Analysis
6.2 Japan CAR-T Cell Therapy Consumption Volume by Type
6.3 Japan CAR-T Cell Therapy Consumption Structure by Application
7 Southeast Asia CAR-T Cell Therapy Market Analysis
7.1 Southeast Asia CAR-T Cell Therapy Consumption and Value Analysis
7.2 Southeast Asia CAR-T Cell Therapy Consumption Volume by Type
7.3 Southeast Asia CAR-T Cell Therapy Consumption Structure by Application
7.4 Southeast Asia CAR-T Cell Therapy Consumption by Top Countries
7.4.1 Indonesia CAR-T Cell Therapy Consumption Volume from 2015 to 2020
7.4.2 Thailand CAR-T Cell Therapy Consumption Volume from 2015 to 2020
7.4.3 Philippines CAR-T Cell Therapy Consumption Volume from 2015 to 2020
7.4.4 Malaysia CAR-T Cell Therapy Consumption Volume from 2015 to 2020
7.4.5 Singapore CAR-T Cell Therapy Consumption Volume from 2015 to 2020
7.4.6 Vietnam CAR-T Cell Therapy Consumption Volume from 2015 to 2020
8 India CAR-T Cell Therapy Market Analysis
8.1 India CAR-T Cell Therapy Consumption and Value Analysis
8.2 India CAR-T Cell Therapy Consumption Volume by Type
8.3 India CAR-T Cell Therapy Consumption Structure by Application
9 Brazil CAR-T Cell Therapy Market Analysis
9.1 Brazil CAR-T Cell Therapy Consumption and Value Analysis
9.2 Brazil CAR-T Cell Therapy Consumption Volume by Type
9.3 Brazil CAR-T Cell Therapy Consumption Structure by Application
10 GCC Countries CAR-T Cell Therapy Market Analysis
10.1 GCC Countries CAR-T Cell Therapy Consumption and Value Analysis
10.2 GCC Countries CAR-T Cell Therapy Consumption Volume by Type
10.3 GCC Countries CAR-T Cell Therapy Consumption Structure by Application
10.4 GCC Countries CAR-T Cell Therapy Consumption Volume by Major Countries
10.4.1 Saudi Arabia CAR-T Cell Therapy Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates CAR-T Cell Therapy Consumption Volume from 2015 to 2020
10.4.3 Qatar CAR-T Cell Therapy Consumption Volume from 2015 to 2020
10.4.4 Bahrain CAR-T Cell Therapy Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 CARsgen Therapeutics, Ltd.
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 CARsgen Therapeutics, Ltd. CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.1.4 CARsgen Therapeutics, Ltd. CAR-T Cell Therapy Sales by Region
11.2 Novartis International AG
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Novartis International AG CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.2.4 Novartis International AG CAR-T Cell Therapy Sales by Region
11.3 Legend Biotech (Genscript Biotech Corporation)
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Legend Biotech (Genscript Biotech Corporation) CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.3.4 Legend Biotech (Genscript Biotech Corporation) CAR-T Cell Therapy Sales by Region
11.4 Celgene Corporation
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Celgene Corporation CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.4.4 Celgene Corporation CAR-T Cell Therapy Sales by Region
11.5 Pfizer, Inc.
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Pfizer, Inc. CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.5.4 Pfizer, Inc. CAR-T Cell Therapy Sales by Region
11.6 Aurora Biopharma Inc
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Aurora Biopharma Inc CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.6.4 Aurora Biopharma Inc CAR-T Cell Therapy Sales by Region
11.7 Sorrento Therapeutics Inc.
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Sorrento Therapeutics Inc. CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.7.4 Sorrento Therapeutics Inc. CAR-T Cell Therapy Sales by Region
11.8 Kite Pharma, Inc. (Gilead Sciences, Inc.)
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Kite Pharma, Inc. (Gilead Sciences, Inc.) CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.8.4 Kite Pharma, Inc. (Gilead Sciences, Inc.) CAR-T Cell Therapy Sales by Region
11.9 Mustang Bio, Inc.
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Mustang Bio, Inc. CAR-T Cell Therapy Sales, Price, Revenue, Gross Margin
11.9.4 Mustang Bio, Inc. CAR-T Cell Therapy Sales by Region
13 Global CAR-T Cell Therapy Market Forecast (2020-2028)
13.1 Global CAR-T Cell Therapy Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global CAR-T Cell Therapy Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global CAR-T Cell Therapy Value and Growth Rate Forecast (2020-2028)
13.1.3 Global CAR-T Cell Therapy Price and Trend Forecast (2020-2028)
13.2 Global CAR-T Cell Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global CAR-T Cell Therapy Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global CAR-T Cell Therapy Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global CAR-T Cell Therapy Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global CAR-T Cell Therapy Consumption Forecast by Type (2020-2028)
13.3.2 Global CAR-T Cell Therapy Revenue Forecast by Type (2020-2028)
13.3.3 Global CAR-T Cell Therapy Price Forecast by Type (2020-2028)
13.4 Global CAR-T Cell Therapy Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
